174 related articles for article (PubMed ID: 21393224)
1. In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.
Russo TA; Page MG; Beanan JM; Olson R; Hujer AM; Hujer KM; Jacobs M; Bajaksouzian S; Endimiani A; Bonomo RA
J Antimicrob Chemother; 2011 Apr; 66(4):867-73. PubMed ID: 21393224
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii.
Higgins PG; Stefanik D; Page MG; Hackel M; Seifert H
J Antimicrob Chemother; 2012 May; 67(5):1167-9. PubMed ID: 22294643
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.
Hornsey M; Phee L; Stubbings W; Wareham DW
Int J Antimicrob Agents; 2013 Oct; 42(4):343-6. PubMed ID: 23837926
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
5. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.
Hofer B; Dantier C; Gebhardt K; Desarbre E; Schmitt-Hoffmann A; Page MG
J Antimicrob Chemother; 2013 May; 68(5):1120-9. PubMed ID: 23344577
[TBL] [Abstract][Full Text] [Related]
7. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli.
Page MG; Dantier C; Desarbre E
Antimicrob Agents Chemother; 2010 Jun; 54(6):2291-302. PubMed ID: 20308379
[TBL] [Abstract][Full Text] [Related]
8. Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters.
Mushtaq S; Warner M; Livermore D
J Antimicrob Chemother; 2010 Feb; 65(2):266-70. PubMed ID: 19996139
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Fe uptake systems and AmpC β-lactamase in susceptibility to the siderophore monosulfactam BAL30072 in Pseudomonas aeruginosa.
van Delden C; Page MG; Köhler T
Antimicrob Agents Chemother; 2013 May; 57(5):2095-102. PubMed ID: 23422914
[TBL] [Abstract][Full Text] [Related]
10. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of BAL30072 against Burkholderia pseudomallei.
Mima T; Kvitko BH; Rholl DA; Page MG; Desarbre E; Schweizer HP
Int J Antimicrob Agents; 2011 Aug; 38(2):157-9. PubMed ID: 21596528
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
Mataracı Kara E; Yılmaz M; Özbek Çelik B
J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
[TBL] [Abstract][Full Text] [Related]
13. Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
Sun Y; Wang L; Li J; Zhao C; Zhao J; Liu M; Wang S; Lu C; Shang G; Jia Y; Wen A
Eur J Pharmacol; 2014 Apr; 729():116-22. PubMed ID: 24561048
[TBL] [Abstract][Full Text] [Related]
14. Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.
Straubinger M; Blenk H; Naber KG; Wagenlehner FM
Antimicrob Agents Chemother; 2016 Jun; 60(6):3309-15. PubMed ID: 26976871
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
16. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain.
Ko WC; Lee HC; Chiang SR; Yan JJ; Wu JJ; Lu CL; Chuang YC
J Antimicrob Chemother; 2004 Feb; 53(2):393-5. PubMed ID: 14729739
[TBL] [Abstract][Full Text] [Related]
18. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Mushtaq S; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
[TBL] [Abstract][Full Text] [Related]
19. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.
Liang W; Liu XF; Huang J; Zhu DM; Li J; Zhang J
BMC Infect Dis; 2011 Apr; 11():109. PubMed ID: 21521536
[TBL] [Abstract][Full Text] [Related]
20. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
